Daily Roundup

PME.ASX EML.ASX HZN.ASX MVF.ASX AMS.ASX

Pro Medicus Secures Lucrative Contract Renewal with Northwestern

Pro Medicus Limited has hit another home run, announcing a 5-year, A$37 million contract renewal with Northwestern Medicine, a premier academic health system in Chicago. The renewal for the Visage 7 Viewer platform includes increased minimums and a higher fee per transaction, reflecting the growth in Northwestern's exam volumes since first adopting the Visage solution five years ago.

Pro Medicus CEO Dr. Sam Hupert couldn't be more pleased, stating the renewal "underpins the belief that the Visage solution provides unparalleled return on investment from both a financial and clinical perspective." This latest deal is part of a string of nearly A$80 million in renewals secured by the company in the last month, further cementing Pro Medicus' reputation for client retention.

EML Payments Revises Guidance Amid Delays and Macro Headwinds

It's been a mixed bag for EML Payments, who have revised their FY26 underlying EBITDA guidance from $58-$60 million down to $47-$50 million. The culprit? Delays in program implementations and weaker trading in the company's northern hemisphere businesses, reflecting softer consumer demand and broader economic uncertainty.

But it's not all doom and gloom. EML's strategic initiatives, including Project Arlo and the development of a global mobility solution, remain firmly on track. The company is also positioning itself to focus on higher margin, higher growth areas of its portfolio. With operating expenses well managed, EML is navigating the current challenges proactively.

Cue and Central Petroleum Secure Gas Supply Deals to Fuel Growth

The Aussie energy sector is buzzing with activity, as Cue Energy Resources and Central Petroleum both ink lucrative gas supply agreements with the Northern Territory Government.

Cue has secured a multi-year deal to supply up to 3.2 PJ of gas from its Palm Valley field through 2034, underpinning the decision to drill two new wells. This adds long-term contracted cashflow and underwrites investment in increased production capacity.

Over at Central Petroleum, a similar agreement will see the company supply up to 10.5 PJ of gas from Palm Valley, also supporting the drilling of two new wells. If successful, these wells could initially boost Central's gas production by around 40%.

Both companies are positioning themselves to capitalize on the growing demand for gas in the Northern Territory, with these deals providing pricing certainty and take-or-pay provisions to strengthen their forward revenue profiles.

Monash IVF Receives Revised Takeover Proposal

In other news, Monash IVF Group has received a revised, unsolicited takeover proposal from a consortium comprising Genesis Capital and WHSP Holdings. The new indicative offer price of $0.90 per share represents an increase from the previous $0.80 per share proposal.

The Monash IVF Board is currently assessing the revised offer, with the help of financial and legal advisers. Shareholders are advised to take no action at this stage, as there's no guarantee the discussions will result in a transaction.

Atomos Expands Product Ecosystem with Flanders Scientific Acquisition

Rounding out the day's announcements, Atomos Limited has signed an agreement to acquire Flanders Scientific, Inc., a global provider of professional reference monitors. The $2.35 million cash and share deal will accelerate Atomos' expansion into the reference monitor market, broadening its product set to support the entire video production workflow.

Atomos CEO James Kirby is excited about the synergies, noting that "FSI combines world-class expertise in colour science and reference display technology with Atomos' global reach, product innovation, balance sheet flexibility, and connected ecosystem." The acquisition is expected to be earnings accretive, with FSI having averaged $11 million in revenue and $0.45 million in EBITDA over the past five years.